Trial Profile

An Adaptive Phase I/II, Dose-Escalation, Multi-centric, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Immunogenicity of ZyCoV-D in Healthy Adult Volunteers

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 24 Aug 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

20 Aug 2021 According to a Zydus Cadila media release, results of the phase I part of this trial have published in the EClinical Medicine Journal of Lancet.
03 Jan 2021 According to a Zydus Cadila media release, this trial has reviewed by an independent Data Safety Monitoring Board (DSMB) and reports were submitted to Central Drugs Standard Control Organisation (CDSCO) regularly for the update on safety outcome.
24 Dec 2020 Status changed to completed, according to a Zydus Cadila media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com